Skip to main content
. 2026 Apr 16;17:1722781. doi: 10.3389/fimmu.2026.1722781

Figure 1.

PRISMA flow diagram illustrating study identification, screening, and inclusion processes for a systematic review. Two columns represent studies found via databases and registers versus citation searching, with numbers of records at each stage and reasons for exclusions noted. Fifty studies were included in the review.

Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews (PRISMA-ScR) flowchart of the study selection process. ICIs, immune checkpoint inhibitors. CirAEs, cutaneous immune-related adverse events.